https://www.selleckchem.com/products/secinh3.html
Next, a head-to-head study in the HFS-Mkn identified median time-to-extinction for standard therapy of 38.7 [95% CI 29.1-53.2) days, isoniazid-rifampin-ethambutol-moxifloxacin of 21.7 [95% CI 19.1-25) days, isoniazid-rifampin-moxifloxacin of 22 [96% CI 20.1-24.5) days, and rifampin-moxifloxacin-tedizolid of 20.7 [95% CI18.5-29) days. Our transformation-factor based translation predicted the proportion of patients of 90.7 [88.74-92.35)% achieving cure with standard therapy at 12 months, and 6-months cure rates of 99.8 [95% CI 99.27-99.95
Like
Comment
Share
